Article
TMScal: A Clinical Decision Support Tool for Prognostic Stratification of Microsatellite-Stable Cancers
2026-08-24
Abstract excerpt
PURPOSE Microsatellite-stable (MSS) cancers comprise 70–85% of patients but lack prognostic biomarkers to guide clinical decision-making. Current metrics—tumor mutational burden (TMB), copy number variation (CNV), and microsatellite instability (MSI)—measure the quantity of genomic instability but discard sequence-context information that encodes repair pathway activity. We developed TMScal, a clinical decision su...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2135b0a8-fc1c-5890-b201-403c2c29f5b9
- DOI
- 10.20944/preprints202608.1628.v1
